Cargando…

Phenotypic Diversity and Emerging New Tools to Study Macrophage Activation in Bacterial Infectious Diseases

Macrophage polarization is a concept that has been useful to describe the different features of macrophage activation related to specific functions. Macrophage polarization is responsible for a dichotomic approach (killing vs. repair) of the host response to bacteria; M1-type conditions are protecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ka, Mignane B., Daumas, Aurélie, Textoris, Julien, Mege, Jean-Louis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193331/
https://www.ncbi.nlm.nih.gov/pubmed/25346736
http://dx.doi.org/10.3389/fimmu.2014.00500
_version_ 1782338956936871936
author Ka, Mignane B.
Daumas, Aurélie
Textoris, Julien
Mege, Jean-Louis
author_facet Ka, Mignane B.
Daumas, Aurélie
Textoris, Julien
Mege, Jean-Louis
author_sort Ka, Mignane B.
collection PubMed
description Macrophage polarization is a concept that has been useful to describe the different features of macrophage activation related to specific functions. Macrophage polarization is responsible for a dichotomic approach (killing vs. repair) of the host response to bacteria; M1-type conditions are protective, whereas M2-type conditions are associated with bacterial persistence. The use of the polarization concept to classify the features of macrophage activation in infected patients using transcriptional and/or molecular data and to provide biomarkers for diagnosis and prognosis has most often been unsuccessful. The confrontation of polarization with different clinical situations in which monocytes/macrophages encounter bacteria obliged us to reappraise this concept. With the exception of M2-type infectious diseases, such as leprosy and Whipple’s disease, most acute (sepsis) or chronic (Q fever, tuberculosis) infectious diseases do not exhibit polarized monocytes/macrophages. This is also the case for commensals that shape the immune response and for probiotics that alter the immune response independent of macrophage polarization. We propose that the type of myeloid cells (monocytes vs. macrophages) and the kinetics of the immune response (early vs. late responses) are critical variables for understanding macrophage activation in human infectious diseases. Explorating the role of these new markers will provide important tools to better understand complex macrophage physiology.
format Online
Article
Text
id pubmed-4193331
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-41933312014-10-24 Phenotypic Diversity and Emerging New Tools to Study Macrophage Activation in Bacterial Infectious Diseases Ka, Mignane B. Daumas, Aurélie Textoris, Julien Mege, Jean-Louis Front Immunol Immunology Macrophage polarization is a concept that has been useful to describe the different features of macrophage activation related to specific functions. Macrophage polarization is responsible for a dichotomic approach (killing vs. repair) of the host response to bacteria; M1-type conditions are protective, whereas M2-type conditions are associated with bacterial persistence. The use of the polarization concept to classify the features of macrophage activation in infected patients using transcriptional and/or molecular data and to provide biomarkers for diagnosis and prognosis has most often been unsuccessful. The confrontation of polarization with different clinical situations in which monocytes/macrophages encounter bacteria obliged us to reappraise this concept. With the exception of M2-type infectious diseases, such as leprosy and Whipple’s disease, most acute (sepsis) or chronic (Q fever, tuberculosis) infectious diseases do not exhibit polarized monocytes/macrophages. This is also the case for commensals that shape the immune response and for probiotics that alter the immune response independent of macrophage polarization. We propose that the type of myeloid cells (monocytes vs. macrophages) and the kinetics of the immune response (early vs. late responses) are critical variables for understanding macrophage activation in human infectious diseases. Explorating the role of these new markers will provide important tools to better understand complex macrophage physiology. Frontiers Media S.A. 2014-10-10 /pmc/articles/PMC4193331/ /pubmed/25346736 http://dx.doi.org/10.3389/fimmu.2014.00500 Text en Copyright © 2014 Ka, Daumas, Textoris and Mege. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Ka, Mignane B.
Daumas, Aurélie
Textoris, Julien
Mege, Jean-Louis
Phenotypic Diversity and Emerging New Tools to Study Macrophage Activation in Bacterial Infectious Diseases
title Phenotypic Diversity and Emerging New Tools to Study Macrophage Activation in Bacterial Infectious Diseases
title_full Phenotypic Diversity and Emerging New Tools to Study Macrophage Activation in Bacterial Infectious Diseases
title_fullStr Phenotypic Diversity and Emerging New Tools to Study Macrophage Activation in Bacterial Infectious Diseases
title_full_unstemmed Phenotypic Diversity and Emerging New Tools to Study Macrophage Activation in Bacterial Infectious Diseases
title_short Phenotypic Diversity and Emerging New Tools to Study Macrophage Activation in Bacterial Infectious Diseases
title_sort phenotypic diversity and emerging new tools to study macrophage activation in bacterial infectious diseases
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193331/
https://www.ncbi.nlm.nih.gov/pubmed/25346736
http://dx.doi.org/10.3389/fimmu.2014.00500
work_keys_str_mv AT kamignaneb phenotypicdiversityandemergingnewtoolstostudymacrophageactivationinbacterialinfectiousdiseases
AT daumasaurelie phenotypicdiversityandemergingnewtoolstostudymacrophageactivationinbacterialinfectiousdiseases
AT textorisjulien phenotypicdiversityandemergingnewtoolstostudymacrophageactivationinbacterialinfectiousdiseases
AT megejeanlouis phenotypicdiversityandemergingnewtoolstostudymacrophageactivationinbacterialinfectiousdiseases